Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: PROSTATIC NEOPLASMS - RADIOTHERAPY , . Treffer: 12
2019
Beer, L; Polanec, SH; Baltzer, PAT; Schatzl, G; Georg, D; Schestak, C; Dutschke, A; Herrmann, H; Mazal, P; Brendel, AK; Shariat, SF; Ringl, H; Helbich, TH; Apfaltrer, P
4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
PLoS One. 2019; 14(12):e0225673-e0225673
Doi: 10.1371/journal.pone.0225673
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T
The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
World J Urol. 2015; 33(10):1467-1473
Doi: 10.1007/s00345-014-1459-2
Web of Science
PubMed
FullText
FullText_MUG
Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T
The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Eur J Cancer. 2015; 51(5):610-619
Doi: 10.1016/j.ejca.2015.01.002
Web of Science
PubMed
FullText
FullText_MUG
2014
Langsenlehner, T; Thurner, EM; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U
Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.
Strahlenther Onkol. 2014; 190(4):364-369
Doi: 10.1007/s00066-013-0503-2
Web of Science
PubMed
FullText
FullText_MUG
Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, T
Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
Strahlenther Onkol. 2014; 190(3):304-309
Doi: 10.1007/s00066-013-0485-0
Web of Science
PubMed
FullText
FullText_MUG
2013
Langsenlehner, T; Döller, C; Winkler, P; Gallé, G; Kapp, KS
Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins. Different alignment techniques in 3D conformal prostate cancer radiotherapy.
Strahlenther Onkol. 2013; 189(4):321-328
Doi: 10.1007/s00066-012-0303-0
Web of Science
PubMed
FullText
FullText_MUG
2012
Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Gerger, A; Langsenlehner, U
Genetic prediction of radiation-induced morbidity in prostate cancer patients.
Radiother Oncol. 2012; 105(3): 380-381.
Doi: 10.1016/j.radonc.2012.07.009
Web of Science
PubMed
FullText
FullText_MUG
2011
Goldner, G; Sljivic, S; Oismueller, R; Salinger, J; Mittermuller, M; Langsenlehner, T; Harder, W; Kametriser, G; Eiter, H; Nechvile, E
Prostate Cancer Radiotherapy in Austria : Overview on Number of Patients, Intention to Treat, and Treatment Techniques Based on Data from 2007.
Strahlenther Onkol. 2011; 187(5):279-283
Doi: 10.1007/s00066-011-2268-9
Web of Science
PubMed
FullText
FullText_MUG
Langsenlehner, T; Renner, W; Gerger, A; Hofmann, G; Thurner, EM; Kapp, KS; Langsenlehner, U
Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients.
Radiother Oncol. 2011; 98(3):387-393
Doi: 10.1016/j.radonc.2011.01.021
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Langsenlehner, T; Renner, W; Gerger, A; Hofmann, G; Thurner, EM; Kapp, KS; Langsenlehner, U
Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.
Strahlenther Onkol. 2011; 187(12):784-791
Doi: 10.1007/s00066-011-1106-4
Web of Science
PubMed
FullText
FullText_MUG
2010
Fuchsjager, MH; Pucar, D; Zelefsky, MJ; Zhang, ZG; Mo, QX; Ben-Porat, LS; Shukla-Dave, A; Wang, LA; Reuter, VE; Hricak, H
PREDICTING POST-EXTERNAL BEAM RADIATION THERAPY PSA RELAPSE OF PROSTATE CANCER USING PRETREATMENT MRI
INT J RADIAT ONCOL. 2010; 78(3): 743-750.
Doi: 10.1016/j.ijrobp.2009.08.040
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2001
Mayer, R; Klemen, H; Quehenberger, F; Sankin, O; Mayer, E; Hackl, A; Smolle-Juettner, FM
Hyperbaric oxygen--an effective tool to treat radiation morbidity in prostate cancer.
Radiother Oncol. 2001; 61(2):151-156
Doi: 10.1016/S0167-8140(01)00430-3
Web of Science
PubMed
FullText
FullText_MUG